1. Spotlight Webinar Series: 2011 Review of Chemotherapy Treatment in Bile Duct Cancer


    from Cholangiocarcinoma Foundation Added 5,170 3 0

    As part of our ongoing educational series, The Cholangiocarcinoma Foundation is proud to present a review of chemotherapy treatment for bile duct cancer. Dr. Milind Javle from MD Anderson Cancer Center lead us in this webinar. Dr. Javle focused this discussion on current chemotherapy treatments, as well as highlighting some emerging treatment options for bile duct cancer. Introduction by Mark Stephens, The Cholangiocarcinoma Foundation Presentation by Dr. Milind Javle, MD Anderson

    + More details
    • Webinar: Dealing with the Emotions of Diagnosis


      from Cholangiocarcinoma Foundation Added 597 1 0

      " . . . the test results are back and there are tumors on your liver . . ." With those chilling words, the emotional and physical battle begins for those diagnosed with cholangiocarcinoma. Immediate questions may arise as to how to cope, emotionally, with this shocking news. Psychologist Geret Giles discusses the initial impact of diagnosis in an exclusive webinar from cholangiocarcinoma.org. Dr. Giles presented concepts and ideas to help deal with the early emotional stages of fighting this disease. The following topics, among others, were discussed: * Initial Disclosure: Who, What, How, and When to Tell * Balancing Realism and Hope * Making Room for the Disease Without Giving In to It * A Word for Loved Ones We apologize for the audio quality, we're working to resolve the issue for future webinars.

      + More details
      • CEACAM6 as a Biological Marker and Prognostic Factor for Biliary Malignancy


        from Cholangiocarcinoma Foundation Added 148 0 0

        In 2011, The Cholangiocarcinoma Foundation funded two grants through the Conquer Cancer Foundation: the Young Investigator Award and the Long Term International Fellowship Award. The Young Investigator Award was presented to Dr. Flavio Rocha, who has recently moved from the Memorial Sloan-Kettering Cancer Center in New York to the Virginia Mason Medical Center in Seattle. Dr. Rocha is using the $50,000 grant from The Cholangiocarcinoma Foundation to investigate CEACAM6 as a biological marker and prognostic factor for biliary malignancy. We are pleased to have Dr. Rocha joining us to provide an update on this study.

        + More details
        • Webinar: Surgical Management of Cholangiocarcinoma – State of the Art and Beyond


          from Cholangiocarcinoma Foundation Added 203 0 0

          We are pleased to present Dr. Kato’s perspective of the complexity of liver and biliary surgery, says Marion Schwartz, CCF Chief Advocacy Officer. She added: “This potentially curative surgery as well as the benefits of surgical palliation are of great interest to our patient community.” This webinar featured Dr. Tomoaki Kato, a renowned expert in liver and intestinal transplantation and complex abdominal and hepatobiliary surgeries. Since 2008, Dr. Kato has served as Chief of the Division of Abdominal Organ Transplantation at New York-Presbyterian Hospital/Columbia University Medical Center. He has been leading the institution’s liver transplant program, using both deceased and living donor livers. This session focused on current techniques being used for surgical management of cholangiocarcinoma and the promise of potential treatments for patients in the future. There was also a Q&A.

          + More details
          • Caregivers and the emotions of caring for a patient with a terminal illness


            from Cholangiocarcinoma Foundation Added 294 0 0

            Does caring for your loved one leave you feeling overwhelmed with stress, anxiety, depression, and fear? If so, please know that you are not alone, and there are resources available to assist. As part of our ongoing efforts to provide Understanding and support to the patient and caregiver community, The Cholangiocarcinoma Foundation invites you to watch our recorded web-based seminar for caregivers and the emotions of caring for a patient with a terminal illness.

            + More details
            • Types of Cholangiocarcinoma and Treatments


              from Cholangiocarcinoma Foundation Added 737 0 0

              Sumera H. Rizvi, MBBS, a fellow in the division of Gastroenterology and Hepatology at Mayo Clinic, Rochester, discusses the three types of cholangiocarcinoma (bile duct cancer) and some treatments that are available.

              + More details
              • Web Chat: My Toughest Marathon: A Runner’s Perspective on Cancer


                from Cholangiocarcinoma Foundation Added 142 0 0

                Bill is the father of 6 and grandfather of 13. He was diagnosed with cholangiocarcinoma in 2009. In this inspirational video, he shares his “story” and perspective on cancer from a marathon runner’s point-of-view: “I have cancer but I am not going to let it stop me from being an active participant in the most active way that can as a father, spouse, and as a family-head so it becomes the new normal . . . I have a disease, the disease doesn’t have me.”

                + More details
                • Palliative Surgery for Patients with Cholangiocarcinoma


                  from Cholangiocarcinoma Foundation Added 69 0 0

                  Some people with cholangiocarcinoma are unable to be cured because their tumor is either inoperable or has spread. These patients can develop blockages of the bile ducts or intestines causing jaundice, severe itching, nimage1-15ausea and/or vomiting. Palliative surgery or endoscopic procedures may be able to provide relief of symptoms. We will be discussing the role of biliary bypass and stenting for bile duct blockages as well the role of surgery and stenting for intestinal blockages. Dr. Scott Celinski is a surgical oncologist who specializes in treating complex cancers of the liver and pancreas. He currently serves as the Director of the Pancreatic Cancer Research and Treatment Center at Baylor University Medical Center in Dallas, TX. His earned his medical degree from Baylor College of Medicine and performed his residency in General Surgery at George Washington University. He completed fellowships in Surgical Oncology and Hepatobiliary Surgery (at the University of Pittsburgh) and Critical Care (at George Washington University). When not at the hospital, Dr. Celinski enjoys beekeeping, gardening, and spending time with his wife and daughter.

                  + More details
                  • Webinar: Using Patients’ Own Immune System to Knock-out Cancer: Adoptive Cell Therapy


                    from Cholangiocarcinoma Foundation Added 369 0 0

                    Join Dr. Steven A. Rosenberg (National Cancer Institute) and Dr. Eric Tran (National Institutes of Health) in a webinar about NIH clinical trial NCT01174121 using adoptive cell therapy, a technique that harnesses a person’s own immune system to battle cancer. Dr. Rosenberg, M.D., Ph.D, a pioneer in the development of adoptive cell therapy, discussed the background, objectives and frequently asked questions about this clinical trial. Dr. Tran, Ph.D., explained how scientists at the NIH were able to grow billions of immune cells that were infused back into patients to melt away tumors and how this therapy could apply to a wide range of cancers. Melinda Bachini shared her journey as a cholangiocarcinoma patient and participant in this ground-breaking clinical trial.

                    + More details

                    What are Tags?


                    Tags are keywords that describe videos. For example, a video of your Hawaiian vacation might be tagged with "Hawaii," "beach," "surfing," and "sunburn."